Moreover, there is a substantial difference in survival rates between different stages, with a more than 10-fold decrease in survival between stage I and stage IV cases.[10,19] To the best of our knowledge, this is the first reported case of c.1758dup mutation in the MLH1 promoter in a patient with LS and SBC. Here, MLH1 is linked to Leigh syndrome.